<DOC>
	<DOCNO>NCT00996164</DOCNO>
	<brief_summary>The object trial ass safety efficacy 24 week course flibanserin treatment hypoactive sexual desire disorder premenopausal woman .</brief_summary>
	<brief_title>Fixed 100 mg Every Evening Flibanserin v Placebo Premenopausal Women With Hypoactive Sexual Desire Disorder</brief_title>
	<detailed_description />
	<mesh_term>Sexual Dysfunctions , Psychological</mesh_term>
	<criteria>Inclusion criterion : 1 . Premenopausal woman 18 year old old 2 . Primary diagnosis hypoactive sexual desire disorder , generalize acquire type accord Diagnostic Statistical Manual Mental Disorder , Fourth Edition , Text Revision , least 24 week duration . 3 . Stable , monogamous heterosexual relationship least one year . 4 . Willing discuss sexual issue . 5 . Willing engage sexual activity least month 6 . Normal pap smear 7 . Must use medically acceptable method contraception 8 . Able comply daily use handheld entry device Exclusion criterion : 1 . Patients take medication protocol List Prohibited Medications within 30 day screen visit . 2 . Patients meet Diagnostic Statistical Manual Mental Disorder , Fourth Edition , Text Revision : Sexual aversion disorder , substance induce sexual dysfunction , Dyspareunia , vaginismus , gender identity disorder , paraphilia , sexual dysfunction general medical condition . 3 . Partner inadequately treat organic psychosexual dysfunction 4 . History Major Depressive Disorder within six month prior screen visit history suicidal behavior . 5 . Sexual function impair psychiatric disorder 6 . Sexual function impair gynecological disorder 7 . Major life stress could impair sexual function 8 . Substance abuse</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>